Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23180178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
Condition: Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo

Indicates status has not been verified in more than two years